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osting by EAbstract Background: Balloon atrial septostomy (BAS) was ﬁrst described by Rashkind and
Miller in 1966 and remains an important interventional procedure in the palliation of certain forms
of congenital heart disease (CHD). Creating an atrial septa1 defect in patients with transposition of
the great arteries (d-TGA) will enhance bidirectional mixing of the pulmonary and systemic venous
blood, hence improving oxygen saturation. The aim of the work is to review and report our expe-
rience using balloon atrial septostomy in different CHD.
Method: We retrospectively reviewed the hospital records, echocardiographic and cardiac catheter-
ization reports of patients subjected for BAS during the period from January 2001 till January 2010.
One hundred and ninety two patients with CHD (78.5% d-TGA, 10% mitral atresia, 7.5% tricuspid
atresia, and 4% hypoplastic left heart syndrome) underwent BAS. Their gestational age was
38.63 ± 1.48 weeks, postnatal age (median 3.5 days, range 1–54) and weight 3.08 ± 0.37 kg,
57.5% was male and 42.5% was female. All patients received PGE1 infusion before the procedure
to maintain the ductal patency in a dose of 0.05–0.1 lg/kg/min.
Results: One hundred twenty two procedures (63.5%) were done in neonatal intensive care at bed-
side and 70 procedures (36.5%) in the catheterization laboratory. General anesthesia was used in
31.3% of patients whereas conscious sedation was used in 68.7% of patients. Femoral access inpartment of Pediatrics, Pedi-
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126 M. Matter et al.78% while umbilical access in 22%. Seven F sheath was used in 100% of case. The Miller catheter
was used in 75% and a Z-5 septostomy catheter in 25% of cases. The diameter of the atrial com-
munication increased from 2.75 ± 0.97 mm to 7.07 ± 0.79 mm (p< 0.0001). Oxygen saturations
increased signiﬁcantly from 65.38 ± 9.59% to 88.62 ± 3.13% (p< 0.0001). Mean pressure gradi-
ent for patients done in catheterization laboratory decreased from 4.1 ± 2.4 to 0.5 ± 1.1 mmHg
(p< 0.0001). The number of septostomies required to achieve good results was 5.23 ± 1.20. No
signiﬁcant difference in oxygen saturation or the size of inter-atrial communication was observed
between the two used balloons (p= 0.6).
Conclusion: BAS is safe and an effective palliative procedure for different CHD with good imme-
diate results in our institution.
ª 2011 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Balloon atrial septostomy (BAS) remains an important inter-
ventional procedure in the palliation of certain forms of con-
genital heart disease (CHD) and considered by many to be
the bread and butter of pediatric catheter intervention.1 BAS
was ﬁrst described by Rashkind and Miller2 in 1966 and re-
mains an important interventional procedure in the palliation
of certain forms of CHD. Typically it is performed in the car-
diac catheterization laboratory under ﬂuoroscopic guidance
with hemodynamic monitoring. This procedure involves trans-
port of a sick, cyanotic infant to the cardiac catheterization
laboratory, often with some time delay from diagnosis to the
start of BAS. Bedside BAS signiﬁcantly reduces the cost to
the patient without a change in efﬁcacy and might be safer
by obviating the need for transport of a sick infant to the car-
diac catheterization laboratory.3 The aim of the work is to re-
view and evaluate our experience over the last 10 years.Figure 1 Contrast ﬁlled balloon in the left atrium and pulled
against the atrial septum under ﬂuroscopy.2. Patients
2.1. Study population
From January 2001 till January 2010, we retrospectively re-
viewed the hospital records, echocardiographic and cardiac
catheterization reports of patients with cyanotic congenital
heart disease, who needed the presence of an adequate intera-
trial shunt to guarantee the survival until the moment when the
palliative or deﬁnitive surgical treatment could be carried out.
One hundred and ninety two patients with different CHD (d-
TGA, mitral atresia, tricuspid atresia, and hypoplastic left
heart syndrome) were admitted to the pediatric or neonatal
intensive and underwent BAS. The diagnosis was conﬁrmed
in all patients by 2-dimensional echocardiography with Dopp-
ler and color ﬂow Doppler. The equipment used for the echo-
cardiographic assessment was (SONOS-5500, Hewlett Packard
Andover, MA) with 12 MHz probe incorporating color ﬂow,
pulsed wave and continuous wave Doppler. Images were re-
corded on videotapes. Therapy for all patients was routinely
begun with prostaglandin E1 in a dose of 0.05–0.1 lg/kg/min
to maintain ductal patency. Their gestational age was
38.63 ± 1.48 weeks, postnatal age (median 3.5 days, range 1–
54) and weight 3.08 ± 0.37 kg, 57.5% was male and 42.5%
was female. The decision to perform the BAS was made based
on the clinical ﬁndings of hypoxia, followed by the echocardio-
graphic conﬁrmation of restrictive atrial septal defect, charac-
terized by the absence of visible communication or small-sizecommunication, that is, <2.0 mm or less than one forth of
the total measurement of the interatrial septum measured in
the subcostal position.
3. Methods
3.1. Septostomy catheters
Miller-Edwards Balloon Septostomy Catheter (Edwards Life
sciences, Irvine, CA) is an extruded catheter with a single lu-
men connected to a Latex balloon at the tip. The Latex bal-
loon is very compliant and, in order to be truly effective, it
must be inﬂated with 5–6 cc of ﬂuid to make the balloon even
somewhat non-compliant. With a 4 or 6 cc volume the balloon
reaches approximately 2 cm in diameter, and at that diameter
the balloon does lose most of its compliance. Although not
advertised, the burst volume of these balloons is 10–12 cc.
The precautions and expiration date on these balloons must
be strictly observed, as Latex deteriorates fairly rapidly when
in light and/or with time. These balloons do not have a sepa-
rate true lumen and must be manipulated and positioned visu-
ally using ﬂuoroscopy or echo. They do come with a very ﬁne
stainless steel stylet which is useful, not only for deﬂecting the
tip of the catheter, but also for clearing the very tiny lumen
should it become clogged and prevent deﬂation of the bal-
loon.4 Z-5 septostomy catheter [NuMED, Inc., Hopkinton,
NY]) has been designed for the neonate with CHD requiring
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to 0.5-mm diameter noncompliant balloon made of polymeric
nylon material with a maximal capacity of 2 cc at the distal
end. It has an end-hole that will accommodate a 0.02 I00 guide-
wire. The inﬂated geometry of the balloon is a sphere. There is
a radiopaque imaging band in the middle of the balloon for
accurate positioning in the left atrium. The catheter tip is
angled at 3500 to facilitate entry into the left atrium.1
4. Technique
The protocol we followed has been previously reported.4,5 The
procedure was done in the catheterization laboratory under
ﬂuoroscopic guidance (Fig. 1). In life-saving conditions and
risky neonatal transport, the procedure was performed in the
neonatal intensive care unit as a bedside procedure under
transthoracic echocardiographic guidance; the standard sub-
costal view was mainly used to delineate the interatrial septum
and to guide the balloon catheter from the right atrium to theFigure 2 Subcostal view to guide the balloon through PFO and
creat wide ASD.left atrium via the patent foramen ovale (PFO) or tiny atrial
septal defect (ASD) (Fig. 2).
1. Venous (umbilical/femoral) access is obtained with the
appropriate size sheath.
2. A balloon septostomy catheter (the Miller catheter
[Edwards-Baxter Healthcare Corporation, Santa Ana,
CA] or the Z-5 septostomy catheter [NuMED, Inc., Hopk-
inton, NY]) is then advanced through the sheath up to the
right atrium and through the atrial communication to the
left atrium.
3. Appropriate positioning of the balloon at the atrial septum
to avoid any potential complication is of crucial impor-
tance. Abnormal positions of the balloon such as: left atrial
appendage or the right atrial appendage in patients with
juxtaposed right atrial appendage, the left pulmonary veins,
through the left atrioventricular (AV) valve to the left ven-
tricle must be avoided.
4. The balloon is then inﬂated in the left atrium then pulled
into the right atrium using a rapid and forceful jerk.
5. The forceful jerk/pull motion should be stopped at the right
atrium inferior vena cava junction. The catheter should be
pushed back to the mid right atrium then deﬂated as rap-
idly as possible.
6. The deﬂated catheter is advanced to the left atrium and the
procedure is repeated until adequate atrial communication
is achieved and no resistance is felt during passage of the
inﬂated balloon across the defect.
7. At the end of the procedure the balloon is deﬂated and
pulled outside the body.
8. The procedure was done under either general anesthesia or
conscious sedation.
The success criterion of the procedure was the increase in
the peripheral oxygen saturation, the increase in the atrial sep-
tal defect diameter >1/3 of the total septal diameter measured
at the subcostal view or around 5 mm with ample border
motility and clinical improvement. The transatrial gradient
at the pulsed Doppler, both pre and post-procedure, was not
considered a criterion of success, as it presented a wide interob-
server variation related to the angle of insonation.
4.1. Statistical analysis
Data were statistically analyzed with the use of the Statistical
Package for Social Science program (SPSS version 15.0 for
windows, Chicago, IL). The descriptive statistical analysis of
the quantitative variables was carried out by calculating the
median, mean and standard deviations. Student’s t test was
used to compare the values of oxygen saturation and atrial sep-
tal defect diameter and mean interatrial pressure gradient be-
fore and after the procedure. Statistical signiﬁcance was
achieved when P was <0.05.5. Results
One hundred and ninety two patients with CHD (78.5% d-
TGA, 10% mitral atresia, 7.5% tricuspid atresia, and 4%
hypoplastic left heart syndrome) underwent BAS (Fig. 3).
One hundred twenty two procedures (63.5%) were done in
neonatal intensive care unit at bedside and 70 procedures
Figure 3 Types of complex congenital cyanotic heart diseases
subjected for balloon septostomy.
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was used in 31.3% of the patients whereas conscious sedation
was used in 67.7% of the patients. Femoral access was used in
78% of cases while umbilical access was used in 22% of cases.
Seven F sheath was used in 100% of cases. The Miller catheter
was used in 75% and a Z-5 septostomy catheter in 25% of
cases. The diameter of the atrial communication increased
from 2.75 ± 0.97 mm to 7.07 ± 0.79 mm (p< 0.0001). Oxy-
gen saturations increased signiﬁcantly from 65.38 ± 9.59%
to 88.62 ± 3.13% (p< 0.0001). Mean pressure gradient for
patients done in the catheterization laboratory decreased from
4.1 ± 2.4 to 0.5 ± 1.1 mmHg (p< 0.0001) (Table 1). The
number of septostomies required to achieve good results was
5.23 ± 1.20. No signiﬁcant difference in oxygen saturation
or the size of inter-atrial communication was observed between
the two used balloons (p= 0.6). Complications encountered
were premature ectopic beats in 54% of cases, supraventricular
tachycardia (SVT) in 8% of cases and venous thrombosis in
2% of cases. Cardiac perforation of left atrial appendage
(LAA) occurred in one patient and managed surgically. Bal-
loon rupture occurred in 7% of cases and all ruptured balloons
were of Miller type, no embolization of balloon fragments was
reported. There were no procedural deaths and ﬁve patients
developed a sepsis-like picture after the procedure and died.
6. Discussion
Balloon atrial septostomy (BAS) was ﬁrst described in 1966 by
Rashkind and Miller2 as palliation for patients with transposi-
tion of the great arteries to improve saturation. When intro-
duced, the technique of BAS was the most important single
factor inﬂuencing survival in patients with TGA. Creating a
nonrestrictive atrial communication optimizes mixing at the
atrial level, improving systemic arterial oxygen content and
cardiac output as well as lowering the left atrial pressure.Table 1 Immediate effect of BAS.
Pre-BAS Post-BAS P
Diameter of ASD (mm) 2.75 ± 0.97 7.07 ± 0.79 <0.0001
Oxygen saturation (%) 65.38 ± 0.59 88.62 ± 3.13 <0.0001
Mean pressure
gradient (mm Hg)
4.1 ± 2.4 0.5 ± 1.1 <0.0001
ASD; Atrial septal defect.These beneﬁcial effects often lead to a rapid stabilization of
these neonates and improve their condition before they under-
go a major neonatal operation.6
BAS is a life-saving procedure for patients born with d-
TGA. The use of prostaglandins, however, has reduced its
need in patients with restrictive atrial septal defects with poor
mixing of saturated atrial blood whose preductal saturations
cannot be maintained in an acceptable range or in those whose
surgery will be delayed for some reason.7
In the early era of the arterial switch operation when an
emphasis was placed on the systemic left ventricular pressures,
a 2-coronary system, and no semilunar valve or subvalve ste-
nosis, cardiac catheterization was an integral part of the eval-
uation. In the recent era, cardiac surgeons have solved the
technical problems, and the need for hemodynamic evaluation
with direct pressure measurements has become less important.
The use of echocardiography in diagnosing d-TGA is the stan-
dard of care and has been used for 15 years. The atrial septum
can be easily evaluated by subcostal imaging, making it an
ideal method for monitoring BAS.8
In fact, echocardiographic guidance is helpful for the bal-
loon position in the left atrium9 and BAS can be performed
at the bedside if safe, reliable, vascular access can be obtained
and catheter movement and position veriﬁed. All of these can
be accomplished at the bedside using the umbilical vein or fem-
oral vein and echocardiographic imaging of the catheter course
and position within the heart because the catheter and wires
used are echo dense as described before.10,11
We have shown that the use of transthoracic echocardiog-
raphy and BAS at the bedside is safe and effective and accom-
panied by very little morbidity. Similar improvement in oxygen
saturation obtained after BAS indicates equal efﬁcacy at the
bedside or in the catheterization laboratory. We tried to avoid
the transport of the sick newborn to the catheterization labo-
ratory reducing the delay from diagnosis to septostomy, more-
over there is no radiation exposure and the result of the
procedure can be veriﬁed as the procedure takes place. The
limitations of transthoracic echo guidance of BAS include
the possibility of poor echo window in an ill neonate on as-
sisted ventilation and possible interference with maneuverabil-
ity for either echocardiographer or catheter operator
particularly when umbilical vein cannulation is performed.
This makes an indication to do the procedure in the catheter-
ization laboratory or under guidance of transesophageal echo-
cardiography as previously described.12
We agree with Baker et al.13 and Perry et al.14 that full car-
diac catheterization is not required for the initial diagnosis or
assessment of neonates with d-TGA and BAS is best per-
formed in the neonatal intensive care unit under 2D control.
Although the concept made by Baker et al.13 that cardiac cath-
eterization remained an integral part of the evaluation of d-
TGA in the early era of the arterial switch operation, patients
still have unanswered critical questions after full echocardio-
graphic evaluation.
In our study, bedside septostomy was markedly less expen-
sive than its cardiac catheterization laboratory counterpart.
Potential savings include reduced fees for transport, for use
of the cardiac catheterization laboratory, and for personnel
(including overtime for callbacks in the middle of the night),
and reduced physician charges.
The study was limited by the retrospective nature of the re-
view. Additionally, the spectrum of disease and underlying
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tors effecting outcomes.
7. Conclusion
The balloon atrial septostomy using ﬂuoroscopy or 2D-ECHO
is an acknowledged technique in the palliative treatment of
cyanotic CHD in hypoxemic neonates due to inadequate intra-
cardiac mix. BAS is safe and effective palliative procedure for
different CHD with good immediate results in our institution.
BAS improves the hemodynamics in a variety of compromised
circulations and is similarly effective in palliation until deﬁni-
tive surgery can be attempted.
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